These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15787087)

  • 1. Functional ability of patients on dialysis: the critical role of anemia.
    Breiterman-White R
    Nephrol Nurs J; 2005; 32(1):79-82. PubMed ID: 15787087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life in patients on dialysis: benefits of maintaining a hemoglobin of 11 to 12 g/dL.
    Gregory N
    Nephrol Nurs J; 2005; 32(3):307-10. PubMed ID: 16035472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of higher hemoglobin levels on health-related quality of life parameters.
    Gregory N
    Nephrol Nurs J; 2003 Feb; 30(1):75-8. PubMed ID: 12674955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anemia and postoperative rehabilitation.
    Carson JL; Terrin ML; Jay M
    Can J Anaesth; 2003; 50(6 Suppl):S60-4. PubMed ID: 14629055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The exercise-during-hemodialysis program: report on a pilot study.
    Ridley J; Hoey K; Ballagh-Howes N
    CANNT J; 1999; 9(3):20-6. PubMed ID: 15712469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical functioning in end-stage renal disease patients: update 2005.
    Painter P
    Hemodial Int; 2005 Jul; 9(3):218-35. PubMed ID: 16191072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is needed to achieve a hemoglobin of 11.0-13.0 g/dl in end-stage renal disease.
    Fishbane S
    Blood Purif; 2007; 25(1):53-7. PubMed ID: 17170538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regarding the optimal hemoglobin target range in renal anemia].
    Maurin N
    Med Klin (Munich); 2008 Sep; 103(9):633-7. PubMed ID: 18813886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal treatment of renal anaemia (OPTA): improving the efficacy and efficiency of renal anaemia therapy in haemodialysis patients receiving intravenous epoetin.
    Hörl WH; Vanrenterghem Y; Canaud B; Mann J; Teatini U; Wanner C; Wikström B
    Nephrol Dial Transplant; 2005 May; 20 Suppl 3():iii25-32. PubMed ID: 15824127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
    Voravud N; Sriuranpong V
    J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and long-term effects of an exercise program for dialysis patients prescribed in hospital and performed at home.
    Malagoni AM; Catizone L; Mandini S; Soffritti S; Manfredini R; Boari B; Russo G; Basaglia N; Zamboni P; Manfredini F
    J Nephrol; 2008; 21(6):871-8. PubMed ID: 19034871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa.
    Lefebvre P; Vekeman F; Sarokhan B; Enny C; Provenzano R; Cremieux PY
    Curr Med Res Opin; 2006 Oct; 22(10):1929-37. PubMed ID: 17022852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morbidity and mortality in patients on dialysis: the impact of hemoglobin levels.
    Brattich M
    Nephrol Nurs J; 2006; 33(1):64-7, 90; quiz 68-9. PubMed ID: 16538929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of exercise training on exercise aerobic capacity and quality of life in hemodialysis patients.
    Capitanini A; Cupisti A; Mochi N; Rossini D; Lupi A; Michelotti G; Rossi A
    J Nephrol; 2008; 21(5):738-43. PubMed ID: 18949729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: a randomized trial.
    Klinger M; Arias M; Vargemezis V; Besarab A; Sulowicz W; Gerntholtz T; Ciechanowski K; Dougherty FC; Beyer U
    Am J Kidney Dis; 2007 Dec; 50(6):989-1000. PubMed ID: 18037099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of interval-training on fatigue and functional capacities in Charcot-Marie-Tooth disease.
    El Mhandi L; Millet GY; Calmels P; Richard A; Oullion R; Gautheron V; Féasson L
    Muscle Nerve; 2008 May; 37(5):601-10. PubMed ID: 18335470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of endurance training on extrarenal potassium regulation and exercise performance in patients on haemodialysis.
    Petersen AC; Leikis MJ; McMahon LP; Kent AB; McKenna MJ
    Nephrol Dial Transplant; 2009 Sep; 24(9):2882-8. PubMed ID: 19389866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
    Voravud N; Sriuranpong V; Suwanrusme H
    J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly.
    Sulowicz W; Locatelli F; Ryckelynck JP; Balla J; Csiky B; Harris K; Ehrhard P; Beyer U;
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):637-46. PubMed ID: 17699476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.